Oxford Biomedica (UK) Limited

United Kingdom

Create a watch for Oxford Biomedica (UK) Limited
Total IP 57
Total IP Rank # 24,478
IP Activity Score 2.4/5.0    33
IP Activity Rank # 22,987
Parent Entity Oxford BioMedica plc
Dominant Nice Class Chemical and biological material...

Patents

Trademarks

20 1
4 0
31 0
1
 
Last Patent 2025 - Viral vector production system
First Patent 1993 - Compositions and methods for can...
Last Trademark 2017 - OXFORD BIOMEDICA
First Trademark 2009 - OCQUILA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Viral vector production system. Disclosed herein are viral vector production systems secreting n...
2023 Invention Envelope proteins. The invention relates to a viral vector production system. More specifically, ...
Invention Retroviral vector. A cell for producing retroviral vectors comprising nucleic acid sequences enco...
2022 Invention Purification method of viral vectors. A method of purifying a viral vector preparation is descri...
Invention Purification method of viral vectors. A method of purifying a viral vector preparation is describ...
Invention Lentiviral vectors. The invention relates to the production of lentiviral vectors. More specific...
Invention Lentiviral vectors. The invention relates to production of lentiviral vectors. More specifically,...
Invention Lentiviral vectors. The invention relates to the production of lentiviral vectors. More specifica...
Invention Novel viral regulatory elements. The present invention relates to novel nucleotide sequences, and...
Invention Retroviral vectors. The invention relates to the production of retroviral vectors. More specifica...
Invention Method. The present invention relates to immunotherapeutic approaches to treating haematological...
2021 Invention Preparation of a solution of polymer/nucleic acid complexes. The invention relates to the prepar...
Invention Preparation of a solution of polymer/nucleic acid complexes. The invention relates to the prepara...
Invention Viral vector production. The present invention provides novel methods for producing a viral vect...
Invention Viral vector production. The present invention provides novel methods for producing a viral vecto...
Invention Lentiviral vectors. The present invention provides a lentiviral vector genome comprising at leas...
Invention Lentiviral vectors. The present invention provides a lentiviral vector genome comprising at least...
Invention Replication competent virus assay. The present invention provides a novel method for detecting r...
Invention Replication competent virus assay. The present invention provides a novel method for detecting re...
Invention Production of lentiviral vectors. A nucleotide sequence encoding the RNA genome of a lentiviral ...
Invention Production of lentiviral vectors. A nucleotide sequence encoding the RNA genome of a lentiviral v...
2020 Invention Production system. The present invention relates to a nucleic acid sequence comprising a nucleot...
Invention Production system. The present invention relates to a nucleic acid sequence comprising a nucleoti...
Invention Enhancing production of lentiviral vectors. A modified U1 snRNA, wherein said modified U1 snRNA ...
Invention Enhancing production of lentiviral vectors. A modified U1 snRNA, wherein said modified U1 snRNA h...
Invention Gene therapy compositions and methods for treating parkinson's disease. A method of improving mo...
Invention Gene therapy compositions and methods for treating parkinson's disease. A method of improving mot...
2019 Invention Viral vector production system. The present invention relates to a nucleic acid sequence comprisi...
Invention Catecholamine enzyme fusions. Provided is a construct comprising (i) a nucleotide sequence which ...
Invention Viral vector production system. Disclosed herein are viral vector production systems secreting nu...
2018 Invention Retroviral vector. A cell for producing retroviral vectors comprising nucleic acid sequences enc...
Invention 5t4-targeting agents and methods. The present invention relates to immunotherapeutic approaches t...
Invention Method. The present invention relates to immunotherapeutic approaches to treating haematological ...
2017 G/S [ Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals an...
2016 Invention Factors. A method for determining a prognosis for benefit for a cancer patient receiving immunot...
2015 Invention Virus purification. A process for producing a retroviral or lentiviral vector formulation compris...
2013 Invention Method for vector delivery. Provided is a lentiviral vector for delivery to the brain for use in ...
Invention Antigen. The present invention relates to a novel method for the delivery of agents to tumour ce...
2012 Invention Construct. The present invention provides a construct comprising (i) a nucleotide sequence which ...
Invention Chemo-immunotherapy method. A method of treating or preventing disease, said method comprising a...
2011 Invention Factors. A method for determining a prognosis for benefit for a cancer patient receiving immunoth...
Invention Method for vector delivery. Provided is a lentiviral vector for delivery to the brain for use in...
2009 Invention Method. The present invention provides a method for detecting a 5T4-positive cancer in a subject...
G/S Chemical products for use in industry and science; enzymes; chemical products for in-vitro use in...